The Potential Toxicity of Artificial Sweeteners

Workplace Health and Safety

Volumn 56, Issue 6, 2008, Pages 251-261

  Whitehouse, Christina R ^a   Boullata, Joseph ^a   McCauley, Linda A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACESULFAME; ASPARTAME; DIPEPTIDE; NEOTAME; SACCHARIN; SWEETENING AGENT; THIAZINE DERIVATIVE;

ANIMAL; CALORIC INTAKE; CHEMISTRY; FEMALE; HEALTH EDUCATION; HUMAN; METABOLISM; OCCUPATIONAL HEALTH NURSING; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH; REVIEW; RISK FACTOR; SAFETY;

ANIMALS; ASPARTAME; DIPEPTIDES; ENERGY INTAKE; FEMALE; HEALTH EDUCATION; HUMANS; OCCUPATIONAL HEALTH NURSING; PUBLIC HEALTH; RISK FACTORS; SACCHARIN; SAFETY; SWEETENING AGENTS; THIAZINES;

EID: 51149090841     PISSN: 21650799     EISSN: 21650969     Source Type: Journal    
DOI: 10.1177/216507990805600604     Document Type: Article

References (51)

1. American Dietetic Association. (2004). Position of the American Dietetic Association: Use of nutritive and nonnutritive sweeteners. Journal of the American Dietetic Association, 104(2), 255–275.
2. Arnold D. L. (1983, April). Two-generation saccharin bioassays. Environmental Health Perspectives, 50, 27–36.
3. Arnold D. L. (1984). Toxicology of saccharin. Fundamental and Applied Toxicology, 4(5), 674–685.
4. Aspartame Information Center. (2006). Aspartame Information Center homepage. Retrieved July 1, 2007, from www.aspartame.org.
5. Bellisle F. Drewnowski A. (2007). Intense sweeteners, energy intake and the control of body weight. European Journal of Clinical Nutrition, 61(6), 691–700.
6. Beverage Institute for Health & Wellness. (2006). Beverage science Q&A: Aspartame. Retrieved February 22, 2008, from www.beverageinstitute.org/ingredients/pdf/Aspartame.pdf.
7. Bigal M. E. Krymchantowski A. V. (2006). Migraine triggered by sucralose: A case report. Headache, 46(3), 515–517.
8. Blumenthal H. J. (1997). Chewing gum headaches. Headache, 37(10), 665–666.
9. Butchko H. H. Stargel W. W. (2001). Aspartame: Scientific evaluation in the postmarketing period. Regulatory Toxicology and Pharmacology. 34(3), 221–233.
10. Calorie Control Council. (2007, Fall). Saccharin: How sweet it is. Retrieved April 23, 2008, from www.saccharin.org/facts_policy.html.
11. Centers for Disease Control and Prevention. (2007). US obesity trends 1985–2006. Retrieved February 16, 2008, from www.cdc.gov/nccdphp/dnpa/obesity/trend/maps/index.htm.
12. Dills W. L. (1989). Sugar alcohols as bulk sweeteners. Annual Review of Nutrition, 9, 161–186.
13. EDInformatics. (1999). Science of cooking: Sucralose. Retrieved August 2, 2007, from www.edinformatics.com/math_science/science_of_cooking/sucralose.htm.
14. European Food Safety Authority. (2007). Neotame as a sweetener and flavor enhancer: Scientific opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food. Retrieved February 16, 2008, from www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178659409273.htm.
15. Ferland A. Brassard P. Poirier P. (2007). Is aspartame really safer in reducing the risk of hypoglycemia during exercise in patients with type 2 diabetes? Diabetes Care, 30(7), 59.
16. Filer L. J. Stegink L. D. (1988). Effect of aspartame on plasma phenylalanine concentrations in humans. In Wurtman R. J. Ritter-Walker E. (Eds.), Dietary phenylalanine and brain function (pp. 18–40). Boston: Birkhauser.
17. Food and Drug Administration. (2006). Artificial sweeteners: No calories…sweet! Retrieved August 2, 2007, from www.fda.gov/fdac/features/2006/406_sweeteners.html.
18. Frey G. H. (1976). Use of aspartame by apparently healthy children and adolescents. Journal of Toxicology & Environmental Health, 2(2), 401–415.
19. Fukushima S. Arai M. Nakanowatari J. Hibino T. Okuda M. Ito N. (1983). Differences in susceptibility to sodium saccharin among various strains of rats and other animal species. Gann, 74(1), 8–20.
20. Gallus S. Scotti L. Negri E. Talamini R. Franceschi S. Montella M. et al. (2007). Artificial sweeteners and cancer risk in a network of case-control studies. Annals of Oncology, 18(1), 40–44.
21. Garland E. M. Shapiro R. Wehner J. M. Johnson L. S. Mattson B. J. Khachab M. et al. (1993). Effects of dietary iron and folate supplementation on the physiological changes produced in weaning rats by sodium saccharin exposure. Food & Chemical Toxicology, 31(10), 689–699.
22. Grice H. C. Goldsmith L. A. (2000). Sucralose: An overview of the toxicity data. Food and Chemical Toxicology, 38(Suppl. 2), S1–S6.
23. Health Canada. (2007). Questions and answers: Saccharin. Retrieved April 23, 2008, from www.hc-sc.gc.ca/fn-an/securit/addit/sweeten-edulcor/saccharin_qa-qr_e.html.
24. Institute of Medicine. (2005). Dietary reference intakes for energy, carbohydrates, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, DC: National Academy Press.
25. International Sweeteners Association. (2008). Saccharin fact sheet. Retrieved April 23, 2008, from www.sweeteners.org/pdf/fs-Saccharin_English.pdf.
26. Knopp R. H. Brandt K. Arky R. A. (1976). Effects of aspartame in young persons during weight reduction. Journal of Toxicology and Environmental Health, 2(2), 417–428.
27. Lenoir M. Serre F. Cantin L. Ahmed S. H. (2007). Intense sweetness surpasses cocaine reward. Retrieved February 16, 2008, from www.pubmedcentral.nih.gov/picrender.fcgi?artid=1931610&blobtype=pdf.
28. Lieberman H. R. Caballero B. Emde G. G. Bernstein J. G. (1988). The effects of aspartame on human mood, performance, and plasma amino acid levels. In Wurtman R. J. Ritter-Walker E. (Eds.), Dietary phenylalanine and brain function (pp. 198–200). Boston: Birkhauser.
29. Mayhew D. A. Comer C. P. Stargel W. W. (2003). Food consumption and body weight changes with neotame, a new sweetener with intense taste: Differentiating effects of palatability from toxicity in dietary safety studies. Regulatory Toxicology and Pharmacology, 38(2), 124–143.
30. Mazur R. H. (1984). Discovery of aspartame. In Stegink L. D. Filer L. J. (Eds.), Aspartame: Physiology and biochemistry (pp. 3–9). New York: Marcel Dekker.
31. McLean Baird I. Shephard N. W. Merritt R. J. Hildick-Smith G. (2000). Repeated dose study of sucralose tolerance in human subjects. Food and Chemical Toxicology, 38(Suppl. 2), S123–S129.
32. Mukherjee A. Chakrabarti J. (1997). In vivo cytogenetic studies on mice exposed to acesulfame-K a non-nutritive sweetener. Food and Chemical Toxicology, 35(12), 1177–1179.
33. Negro F. Mondardini A. Palmas F. (1994). Hepatotoxicity of saccharin. The New England Journal of Medicine, 331(2), 134–135.
34. Nofre C. C. Tinti J. M. (2000). Neotame: Discovery, properties, utility. Food Chemistry, 69, 245–257.
35. O'Donnell K. (2005). Carbohydrates and intense sweeteners. In Ashurst P. R. (Ed.), Chemistry and technology of soft drinks and fruit juices (2nd ed., pp. 68–89). Hereford, UK: Blackwell Publishing Ltd.
36. Palese M. Tephly T. R. (1975). Metabolism of formate in the rat. Journal of Toxicology and Environmental Health, 1(1), 13–24.
37. Renwick A. G. (2006). The intake of intense sweeteners: An updated review. Food Additives and Contaminants, 23(4), 327–338.
38. Roberts A. Renwick A. G. Sims J. Snodin D. J. (2000). Sucralose metabolism and pharmacokinetics in man. Food & Chemical Toxicology, 38(Suppl. 2), S31–S41.
39. Roberts H. J. (2007). Aspartame-induced thrombocytopenia. Southern Medical Journal, 100(5), 543.
40. Sedova L. Seda O. Kazdova L. Chylikova B. Hamet P. Tremblay J. et al. (2007). Sucrose feeding during pregnancy and lactation elicits distinct metabolic response in offspring of an inbred genetic model of metabolic syndrome. American Journal of Physiology-Endocrinology & Metabolism, 292(5), E1318–E1324.
41. Soffritti M. Belpoggi F. Tibaldi E. Esposti D. D. Lauriola M. (2007). Lifespan exposure to low doses of aspartame beginning during prenatal life increases cancer effects in rats. Environmental Health Perspectives. 115(9), 1293–1297.
42. Stegink L. D. (1976). Absorption, utilization, and safety of aspartic acid. Journal of Toxicology and Environmental Health, 2(1), 215–242.
43. Stegink L. D. Filer L. J. Baker G. L. (1977). Effect of aspartame and aspartate loading upon plasma and erythrocyte free amino acid levels in normal adult volunteers. Journal of Nutrition, 107(10), 1837–1845.
44. Stegink L. D. Shepherd J. A. Brummel M. C. Murray L. M. (1974). Toxicity of protein hydrolysate solutions: Correlation of glutamate dose and neuronal necrosis to plasma amino acid levels in young mice. Toxicology, 2(3), 285–299.
45. Stokes A. F. Belger A. Banich M. T. Taylor H. (1991). Effects of acute aspartame and acute alcohol ingestion upon the cognitive performance of pilots. Aviation Space & Environmental Medicine, 62(7), 648–653.
46. Sweeteners Holdings, Inc. (2002). Neotame. Retrieved July 8, 2007, from www.neotame.com.
47. Swithers S. E. Davidson T. L. (2008). A role for sweet taste: Calorie predictive relations in energy regulation by rats. Behavioral Neuroscience, 122(1), 161–173.
48. Tennant D. (2002). Estimation of food chemical intake. In Kotsonis F. N. Mackey M. A. (Eds.), Nutritional toxicology (2nd ed., pp. 263–286). New York: Taylor & Francis.
49. Waisman H. A. Harlow H. F. (1965, February 12). Experimental phenylketonuria in infant monkeys: A high phenylalanine diet produces abnormalities simulating those of the hereditary disease. Science, 147, 685–695.
50. Weihrauch M. R. Diehl V. (2004). Artificial sweeteners: Do they bear a carcinogenic risk? Annals of Oncology, 15, 1460–1465.
51. World Health Organization. (2004). Harmonization project document no. 1 IPCS risk assessment terminology: Definition of key terms (pp. 10–15). Geneva: Author.